The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks fall on Chinese data, US growth

Thu, 21st Jun 2012 08:40

- Chinese PMI falls to seven-month low- Fed extends 'the twist', lowers GDP forecast- Miners provide a drag in LondonDisappointing economic data from China and a downward revision to US growth dented the Footsie in early trading on Thursday, with mining stocks bearing the brunt of the sell-off.The Chinese manufacturing sector purchasing managers' index for the month of June compiled by Markit fell from 48.4 to 48.1 in June, a seven-month low. Many observers believe that the Asian powerhouse will bottom-out in the current quarter. Commenting on the Flash China Manufacturing PMI, Hongbin Qu, chief economist, China & Co-Head of Asian Economic Research at HSBC said: "China's manufacturing sector continued to slow in June, though the pace of slowdown seems to be slowing. With external headwinds remaining strong, exports are likely to decelerate in the coming months. The sharp fall of prices and moderation of new orders suggest weak domestic demand, posing destocking pressures for Chinese manufacturers. All will likely weigh on the jobs market. As such, we expect more decisive policy stimulus to reverse the growth slowdown." In other news, the keenly-awaited policy decision in the US last night failed to boost markets as was hoped, after the Federal Reserve also downgraded its growth expectations for the world's largest economy. Fed Chairman Ben Bernanke said that the European crisis was "slowing US economic growth." While the Federal Open Market Committee decided to extend its 'Operation Twist' programme, which involving the sale of short-term debt in exchange for long-term securities with the intention of flattening the interest rate curve, the central bank said it expects US GDP to grow by 1.9-2.4% in 2012, down from earlier predictions of a 2.4-2.9% expansion. In Eurozone news, there were rumours that German Chancellor Angela Merkel has said that bond purchases by the European bail-out funds are a possibility.Company movements: Miners tank after China dataConcerns over the Chinese economy pressured sharp falls in the mining sector this morning as investors expressed worries about slowing demand. Vedanta, Kazakhmys, Xstrata, Glencore, Rio Tinto, BHP Billiton, Antofagasta, Anglo American and Polymetal dominated the fallers list.With investors fleeing from these 'riskier' assets, defensive sectors were in demand with pharmaceuticals group GlaxoSmithKline and AstraZeneca, and tobacco giant BATS on the rise.Water company Severn Trent rose after announcing the launch of a 10-year sterling bond with a coupon linked to the retail prices index. The bonds will pay interest semi-annually at a real rate of interest of 1.3% per annum adjusted to take account of changes in the level of the UK Retail Prices Index (RPI). The bonds, to be issued at £100 a throw, could, however, end up paying less than 1.3% per year if the UK experiences deflation.FTSE 250 construction equipment leasing firm Ashtead Group jumped early on after reporting record profits as tight cost control and strong demand in the US helped the firm beat analyst expectations. Bid talks which got the market excited on Wednesday about Invensys, the maker of rail signalling and industrial automation systems, have hit the buffers already causing shares to pull back. In response to press speculation about an approach from Emerson Electric for some of the company'sassets, news of which leaked out on Wednesday, Invensys said talks with Emerson are no longer taking place. FTSE 100 - RisersGlaxoSmithKline (GSK) 1,479.50p +1.06%Reckitt Benckiser Group (RB.) 3,400.00p +0.98%Unilever (ULVR) 2,077.00p +0.73%Associated British Foods (ABF) 1,242.00p +0.65%Aggreko (AGK) 2,112.00p +0.62%AstraZeneca (AZN) 2,783.00p +0.60%Pearson (PSON) 1,216.00p +0.50%British American Tobacco (BATS) 3,233.50p +0.42%Shire Plc (SHP) 1,952.00p +0.41%Compass Group (CPG) 655.00p +0.38%FTSE 100 - FallersVedanta Resources (VED) 934.00p -4.50%Kazakhmys (KAZ) 721.50p -4.50%Xstrata (XTA) 839.70p -3.49%Glencore International (GLEN) 321.70p -3.47%Rio Tinto (RIO) 2,998.00p -3.13%Weir Group (WEIR) 1,512.00p -2.95%Antofagasta (ANTO) 1,090.00p -2.85%Anglo American (AAL) 2,152.50p -2.82%BHP Billiton (BLT) 1,824.50p -2.72%Eurasian Natural Resources Corp. (ENRC) 425.90p -2.34%FTSE 250 - RisersAshtead Group (AHT) 267.80p +6.95%Stobart Group Ltd. (STOB) 121.70p +2.87%Interserve (IRV) 304.20p +1.47%Micro Focus International (MCRO) 458.40p +1.42%Rank Group (RNK) 122.40p +1.41%Barr (A.G.) (BAG) 435.00p +1.16%Bank of Georgia Holdings (BGEO) 1,011.00p +1.10%Rathbone Brothers (RAT) 1,213.00p +1.08%Aberforth Smaller Companies Trust (ASL) 568.00p +0.89%Dechra Pharmaceuticals (DPH) 487.20p +0.87%FTSE 250 - FallersInvensys (ISYS) 214.60p -16.50%Aquarius Platinum Ltd. (AQP) 54.00p -9.55%Ferrexpo (FXPO) 211.50p -4.94%Afren (AFR) 105.00p -4.20%Man Group (EMG) 74.65p -4.11%Heritage Oil (HOIL) 124.70p -4.08%Bellway (BWY) 775.00p -4.02%Home Retail Group (HOME) 83.60p -3.91%Centamin (DI) (CEY) 66.50p -3.76%Petropavlovsk (POG) 465.70p -3.48%BC
More News
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.